Introduction {#s1}
============

Mild traumatic brain injury (mTBI) occurs at an incidence exceeding 42 million per year worldwide ([@B1]). mTBI is defined as "an acute brain injury resulting from mechanical injury to the head from external physical forces" ([@B2]). The causes of mTBI are numerous, including sporting collisions, blast neurotrauma, and motor vehicle accidents, among others ([@B3]). mTBI is associated with acute neuropsychiatric dysfunction, with depression a commonly described sequel. Many acute symptoms dissipate with resolution of the physiological injury; however, depression may persist (or develop) in the post-acute or chronic time frame ([@B4]). While much is known about the long-term physical and cognitive consequences of mTBI, the mechanisms underlying emotional dysregulation after mTBI are less understood ([@B5]).

Depression has many direct consequences, and elucidation of the burden attributable to depression is essential to understanding the impact of this disorder in the post-mTBI setting. Depression may mediate the relationships between mTBI and poor physical health ([@B6]), diminish functional capacity ([@B7]), impair executive control ([@B4]), and hinder social function ([@B8]). Depression also decreases quality of life after mTBI ([@B7]) and has a substantial personal and economic burden ([@B9]). In studies encompassing TBI of all severities, post-injury depression may occur in over 40% of subjects, with a relative risk of 7.5 ([@B10], [@B11]). The true prevalence of depression in the chronic period following mTBI is uncertain, with most studies focusing on mTBI in the acute phase (days--weeks) as part of a constellation of post-concussive symptoms or on moderate-to-severe injuries. Suggested risk factors for post-TBI depression are heterogeneous across available data; indeed, no clear consensus has emerged regarding such factors such as female sex ([@B11]--[@B13]) and age at injury ([@B14], [@B15]). Moreover, the likelihood of depression following mTBI sustained *via* different injury modalities has not been investigated.

Major depressive disorder (MDD) has a lifetime prevalence of 20.6% and known overlap with mTBI. Given that mTBI is an extremely common injury with an approximate lifetime prevalence of 22% \[range: 12--46% ([@B16])\], the degree of association between mTBI and depression is therefore important to quantify. Evaluation of any causal link between mTBI and depression is problematic due to the heterogeneity of primary injuries and outcomes, late emergence of symptomology, and lack of formal large-scale trials in the area. In lieu of definitive large-scale longitudinal clinical assessments, a meta-analysis of literature spanning decades post-mTBI is the only realistic means to elucidate the association between mTBI and depression and identify the true odds of occurrence.

The aim of this study was to conduct a meta-analysis on all published data assessing depression after adult mTBI from a mean of 6 months post-injury onward to determine the lifetime odds ratio (OR) of depression chronically following an mTBI event.

Methods {#s2}
=======

This study was conducted according to the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Checklist for Meta-analyses of Observational Studies criteria ([eTable 1](#SM1){ref-type="supplementary-material"}).

Search Strategy
---------------

We performed a random-effects meta-analysis. Operational definitions of mTBI and depression \[obtained through Medical Subject Headings (MeSH) thesauruses and non-MeSH terms\] were used to determine the search strategy. Our initial search in PubMed contained the keywords "mild traumatic brain injury," "depression," and "mood disorder" (see [eMethods](#SM1){ref-type="supplementary-material"} for full search strategy). Literature was searched from the date of database inception to January 23, 2019.

Selection Criteria
------------------

Studies were chosen according to the "PICOS" principles, with studies eligible if meeting the following criteria:

1.  Population: Human adults assessed more than 6 months post-injury

2.  Indicator: At least one instance of mTBI

3.  Comparison: A control comparison group matched in age and sex

4.  Outcome: Depression assessed using a measure validated in accordance with the standard operationalized diagnostic criteria \[Feighner criteria, Research Diagnostic Criteria, Diagnostic, and Statistical Manual of Mental Disorders (DSM)-III, DSM-III-R, DSM-IV, DSM-5, and International Classification of Diseases (ICD)-10\].

5.  Study design: Original reports of case-control, cohort, cross-sectional, and prospective observational studies. Where possible, randomized controlled trials were included, provided that baseline (pretreatment) assessments were reported. Due to the nature of mTBI research, the vast majority of studies were non-randomized, thus we included randomized and non-randomized study designs.

Data Extraction
---------------

Three investigators (SH, CB, TW) independently selected the studies and screened articles for exclusion on the basis of title and abstract, followed by review of full manuscripts and [Supplementary Material](#SM1){ref-type="supplementary-material"}. Studies examining moderate or severe TBI, combining injury severities, or including depression when present before injury were excluded. Studies reporting continuous data categorizing subjects as positive or negative for depression symptoms were examined for agreement in questionnaire cutoff values.

Studies straddling exclusion criteria were discussed for agreement among at least two authors. Three investigators (SH, CB, and TW) assessed the risk of bias. Any discrepancies at this stage were resolved by discussion among all authors until consensus was reached.

Outcomes and Sub-analyses
-------------------------

Our primary outcome of interest was presence or absence of depression at any time beyond 6 months post-mTBI. Planned secondary analyses examined the ORs of (1) depression with increasing chronicity post-mTBI from 6 months onward; (2) influence of age at injury (under 25, 25--35, over 35); (3) influence of age at assessment (under 40, over 40); (4) relationship of biological sex and odds of depression; (5) whether mTBIs of different etiologies confer a different risk of depression; (6) whether repeated injuries increase the odds of post-mTBI depression.

Risk of Bias and Study Heterogeneity
------------------------------------

To assess the risk of bias in included studies, we combined the SIGN Methodology Checklist 3 for cohort studies and Checklist 4 for case-control studies. Heterogeneity was quantified using the *I*^2^ test statistic, where an *I*^2^ of below 50% indicates no/low heterogeneity, 50--75% moderate heterogeneity, and above 75% indicates high heterogeneity. Due to expected variation in effect sizes arising from methodological differences and sampling bias inherent to the type of studies examined, heterogeneity was handled by use of a random-effects model. Funnel plots were produced to assess publication bias, with calculation of Failsafe-N ([@B17]). Subgroup analyses (defined under "outcomes") were also planned to determine whether differences in effect sizes were due to variations in methodology ([@B18]).

Data Analysis
-------------

The following information was extracted for each study: measure of depression used in assessment and score for depression (dichotomous data: number classed as depressed for mTBI or control and total number of participants in each group; continuous data: mean and standard deviation for mTBI and control groups). For subgroup analysis, we also extracted mean time since mTBI, mean current age (with age at injury calculated from these two variables if not reported), and etiology of injury classified as sports mTBI, motor vehicle accident (MVA), military injuries or "other/unclassified." In the case of multiple studies reporting data from the same cohort, we included only the study for which the most complete data set was available. We estimated summary ORs for dichotomous data, and mean differences (MDs) for continuous outcomes (see [eMethods](#SM1){ref-type="supplementary-material"} for further information). To combine these data sets, MDs were converted to ORs using the formula of Chinn ([@B19]). We used The Cochrane Collaboration RevMan software ([@B20]) to collate data and produce forest plots, funnel plots, and figures for risk of bias. One-way ANOVAs and Student\'s *T*-tests were calculated to determine statistical differences between subgroups using GraphPad Prism version 7.00 for Mac OS X (GraphPad Software, La Jolla, CA). Unless specified, *p*-values are representative of significance at the meta-analysis level.

Results {#s3}
=======

[Figure 1](#F1){ref-type="fig"} describes the screening process for 1,972 studies assessed for inclusion or exclusion in the meta-analysis. The 82 studies ultimately included in the meta-analysis comprised a total of 392,834 subjects. Thirty-seven studies reported assessment of post-mTBI depression using dichotomous data (361,814 subjects) while 45 reported findings as continuous data (30,991 subjects). [Table 1](#T1){ref-type="table"} summarizes the characteristics of included studies. We included two case-control studies, one randomized trial, 48 cross-sectional studies, 26 cohort studies, and six prospective longitudinal studies. Of the total 392,834 subjects, 96,688 had mTBI and 296,117 were controls. Control subjects fell into the following categories: healthy control or population samples (28 studies), veterans or active military without mTBI (36 studies), sportsplayer peers or peers of cases (13 studies), and non-mTBI injuries or illnesses (five studies; see [eResults 1](#SM1){ref-type="supplementary-material"} for further analysis). In the dichotomous data, the frequency of depression across the mTBI cohorts was 8% compared to 3% across the control cohorts.

![PRISMA flowchart of study selection process.](fneur-11-00350-g0001){#F1}

###### 

Characteristics of studies examining depression chronically after mTBI meeting the criteria for inclusion.

  **Reference**                        **Study type**              **Depression measure**      **Mean age at trauma**   **Mean age at follow-up (SD)**          **Mean time since trauma, years (SD)**   **% F**   **n mTBI**   **n control**   **Control type**
  ------------------------------------ --------------------------- --------------------------- ------------------------ --------------------------------------- ---------------------------------------- --------- ------------ --------------- -------------------------------------------------------------
  Amick et al. ([@B21])                Cross-sectional             NSI-22                      NS                       34.0 (8.6)                              NS                                       6         22,662       26,153          Veterans without mTBI Hx
  Astafiev et al. ([@B22])             Cross-sectional             CES-D                       38.6                     39.8 (11.8)                             1.2 (1.5)                                55        20           22              Healthy control
  Baker et al. ([@B23])                Case control                BDI-II                      NS                       56.7                                    NS                                       0         21           21              Active sportsplayer peers without mTBI Hx
  Baldassrre et al. ([@B24])           Prospective observational   BDI-II                      27.2                     32.0 (8.9)                              4.8 (2.18)                               11        188          210             Veterans without mTBI Hx
  Barnes et al. ([@B25])               Cross-sectional             BDI-II                      NS                       30.3 (8.2)                              NS                                       0         46           46              Veterans without mTBI Hx
  Bell et al. ([@B26])                 Cross-sectional             BDI                         NS                       38.7 (11.3)                             NS                                       55        20           20              Migraine headache
  Bomyea et al. ([@B27])               Cross-sectional             BDI-II                      NS                       32.8 (6.8)                              NS                                       14        52           32              Veterans without mTBI Hx
  Bryant et al. ([@B28])               Cohort                      DSM-IV                      37.8                     38.8 (13.6)                             1.0                                      28        321          321             Hospital sample - other trauma (non-mTBI)
  Callahan et al. ([@B29])             Cohort                      PAS-DEP                     NS                       31.5 (7.6)                              NS                                       2         42           36              Veterans without mTBI Hx
  Carrier-Toutant et al. ([@B30])      Cross-sectional             BDI-II                      19.2                     21.2 (2.49)                             2.0 (0.7)                                51        43           40              Active sportsplayer peers without mTBI Hx
  Chi et al. ([@B31])                  Cohort                      ICD-9                       NS                       NS                                      NS                                       42        55,456       221,501         Healthy control
  Chong et al. ([@B32])                Cohort                      BDI                         29.0                     36.0                                    7.0                                      39        33           33              Healthy control
  Coughlin et al. ([@B33])             Cross-sectional             HAMD                        24.3                     31.3 (6.1)                              7.0 (6.4)                                0         14           16              Healthy control
  Dailey et al. ([@B34])               Cross-sectional             BDI                         21.0                     21.9 (2.8)                              0.9 (0.3)                                73        15           14              Healthy control
  de Almeida Lima et al. ([@B35])      Cross-sectional             HADS                        37.5                     39.0 (2.9)                              1.5                                      49        36           36              Case-control pairing (friends/family)
  Dean and Sterr ([@B36])              Cross-sectional             HADS                        25.7                     26.7 (1.9)                              1.0                                      0         36           36              General public
  Decq et al. ([@B37])                 Cross-sectional             PHQ-9                       NS                       52.0                                    NS                                       0         217          158             Retired sportsplayer peers without mTBI Hx
  Didehbani et al. ([@B38])            Cross-sectional             BDI-II                      NS                       58.6 (10.3)                             NS                                       0         30           29              Healthy control
  Dismuke-Greer et al. ([@B39])        Cohort                      PHQ-9                       28.7                     38.0[^\*^](#TN1){ref-type="table-fn"}   9.3[^\*^](#TN1){ref-type="table-fn"}     13        300          56              Veterans without mTBI Hx
  Donnell et al. ([@B40])              Cohort                      DSM-IV                      NS                       37.8 (2.5)                              NS                                       0         154          3,001           Veterans without mTBI Hx
  Donnelly et al. ([@B41])             Cohort                      BDI-II                      32.1                     33.6 (9.6)                              1.5                                      11        130          225             Veterans without mTBI Hx
  Drapeau et al. ([@B42])              Cross-sectional             BDI-II                      35.8                     36.8 (9.25)                             0.9 (0.7)                                40        20           11              Healthy control
  Dretsch et al. ([@B43])              Cross-sectional             ZDS                         NS                       26.0 (7.0)                              NS                                       6         167          291             Military without mTBI Hx
  Epstein et al. ([@B44])              Cross-sectional             HAMD                        34.5                     35.5 (7.9)                              8.9 (7.8)                                0         55           27              Healthy control
  Gaines et al. ([@B45])               Cross-sectional             BDI-II                      24.5                     29.5 (6.1)                              5.0                                      0         57           57              Veterans without mTBI Hx
  Gardner et al. ([@B46])              Cross-sectional             DASS                        32.5                     38.3 (4.6)                              5.8                                      0         16           16              Healthy control
  Gill et al. ([@B47])                 Cross-sectional             QIDS                        29.8                     31.3 (6.8)                              1.5                                      7         42           22              Healthy control
  Graham et al. ([@B48])               Cross-sectional             CES-D                       30.8                     31.8 (7.6)                              4.3 (2.0)                                5         41           26              Veterans without mTBI Hx
  Guskiewicz et al. ([@B49])           Cohort                      Self-report                 29.1                     53.8 (13.4)                             24.7 (13.7)                              0         1,513        1,039           Retired sportsplayer peers without mTBI Hx
  Himanen et al. ([@B50])              Cohort                      BDI-II                      29.1                     60.1 (10.6)                             31.0 (3.6)                               33        17           31              Healthy control
  Hoge et al. ([@B6])                  Cohort                      PHQ-15                      NS                       NS                                      NS                                       1         368          1673            Military without mTBI Hx
  Hoot et al. ([@B51])                 Cohort                      PHQ-9                       27.1                     36.0[^\*^](#TN1){ref-type="table-fn"}   8.9[^\*^](#TN1){ref-type="table-fn"}     12        376          73              Veterans and service members without mTBI Hx
  Iverson and Pogoda ([@B52])          Cohort                      CES-D                       NS                       51.9 (10.1)                             NS                                       100       33           119             Veterans without mTBI Hx
  Johansson et al. ([@B53])            Cross-sectional             Clinical interview          40.2                     48.5 (1.7)                              6.5 (1.7)                                72        46           40              Healthy control
  Jurick et al. ([@B54])               Cross-sectional             PHQ-9                       28.4                     35.0 (8.1)                              6.6 (4.4)                                9         42           28              Veterans without mTBI Hx
  Kerr et al. ([@B55])                 Cross-sectional             PHQ-9                       NS                       NS                                      NS                                       0         172          32              Former collegiate football peers without mTBI Hx
  Kerr et al. ([@B56])                 Prospective observational   GHS                         NS                       63.1 (11.2)                             NS                                       0         679          365             Retired sportsplayer peers without mTBI Hx
  Konrad et al. ([@B57])               Cross-sectional             BDI                         30.7                     36.7 (12.4)                             6.0                                      48        33           33              Healthy control
  LaFrance et al. ([@B58])             Cross-sectional             BDI-II                      NS                       38.9 (12.6)                             NS                                       66        41           51              Psychogenic non-epileptic seizure (no mTBI Hx)
  Lee et al. ([@B59])                  Cohort                      PHQ-15                      22.4                     27.0 (5.3)                              4.6 (1.9)                                10        182          2,843           Military without mTBI Hx
  Leveille et al. ([@B60])             Cross-sectional             BDI-II                      20.1                     22.7 (2.4)                              2.6 (1.0)                                50        22           28              University athlete peers without mTBI Hx
  Lippa et al. ([@B61])                Cross-sectional             WHODAS                      28.1                     31.2 (7.4)                              3.1 (2.4)                                8         99           156             Veterans without mTBI Hx
  Losoi et al. ([@B62])                Prospective longitudinal    BDI-II                      36.5                     37.0 (11.8)                             0.5                                      39        69           37              Orthopedic injury
  Mac Donald et al. ([@B63])           Prospective observational   DSM-IV; MADRS               27.0                     32.0 (8.0)                              5.0                                      7         50           44              Military without mTBI Hx
  Mac Donald et al. ([@B64])           Prospective observational   BDI                         NS                       26.0[^\*^](#TN1){ref-type="table-fn"}   5.0                                      8         38           34              Military without mTBI Hx
  MacGregor et al. ([@B65])            Cohort                      PDHRA                       22.6                     23.3                                    0.7                                      0         334          658             Military without mTBI Hx
  Maruta et al. ([@B66])               Cross-sectional             CES-D                       33.3                     34.9 (14.0)                             1.6                                      52        33           140             Healthy control
  Mickeviciene et al. ([@B67])         Prospective observational   VAS                         33.7                     36.0 (10.5)                             2.3                                      40        131          146             Age and sex matched minor non-head injury (hospital sample)
  Moller et al. ([@B68])               Cross-sectional             HADS                        34.3                     36.0                                    1.8 (1.6)                                50        24           31              Healthy control
  Morey et al. ([@B69])                Cross-sectional             BDI                         29.9                     39.6 (10.8)                             9.7 (10.8)                               3         30           70              Healthy control + confirmatory controls
  Morissette et al. ([@B70])           Cross-sectional             BDI-II                      NS                       36.9 (9.4)                              NS                                       4         98           115             Veterans without mTBI Hx
  Newberg et al. ([@B71])              Cross-sectional             BDI                         50.5                     51.0 (16)                               0.5                                      44        25           10              Healthy control
  Nordhaug et al. ([@B72])             Cohort                      HADS                        54.7                     59.6 (14.7)                             4.9 (3.2)                                47        294          25,662          Population cohort
  Olivera et al. ([@B73])              Cohort                      QIDS                        NS                       30.4 (4.6)                              NS                                       1         70           28              Military without mTBI Hx
  Ozen and Fernandes ([@B74])          Cross-sectional             BDI                         13.5                     19.8 (1.6)                              6.3 (4.6)                                49        43           44              University peers without mTBI Hx
  Palombo et al. ([@B75])              Cohort                      DSM-IV                      25.3                     29.3 (7.6)                              4.0 (2.2)                                4         50           25              Veterans without mTBI Hx
  Peskind et al. ([@B76])              Cross-sectional             PHQ-9                       28.5                     32.0 (8.5)                              3.5 (1.2)                                0         12           12              Healthy control
  Petrie et al. ([@B77])               Cross-sectional             PHQ-9                       27.8                     31.6 (9.2)                              3.8 (1.5)                                0         34           17              Veterans without mTBI Hx
  Pineau et al. ([@B78])               Cross-sectional             BDI-II                      35.2                     36.8 (15.3)                             1.7 (1.4)                                44        25           25              Healthy control
  Pogoda et al. ([@B79])               Cohort                      ICD-9                       NS                       30.6 (8.2)                              NS                                       5         9,998        3,748           Veterans without mTBI Hx
  Polusny et al. ([@B80])              Cohort                      BDI-II                      30.0                     31.0 (8.0)                              1.0                                      3         60           748             Military (National Guard soldiers) without mTBI Hx
  Raikes et al. ([@B81])               Cohort                      BDI-II                      23.9                     24.9 (8.6)                              0.5                                      62        5            18              Healthy control
  Raskin ([@B82])                      Cross-sectional             BDI                         38.3                     40.4 (11.0)                             2.1 (0.8)                                100       10           10              Healthy control
  Rogers et al. ([@B83])               Cross-sectional             DASS                        20.2                     21.1 (5.6)                              1.3 (0.5)                                40        10           10              University peers without mTBI Hx
  Schiehser et al. ([@B84])            Cross-sectional             BDI-II                      26.4                     33.1 (6.9)                              6.7 (4.5)                                13        60           40              Veterans without mTBI Hx
  Schoenhuber and Gentilini ([@B85])   Case-control                ZDS                         27.3                     28.0 (14.0)                             0.8                                      0         35           35              Case-control pairing (friends/family)
  Small et al. ([@B86])                Cohort                      HAMD                        NS                       59.0[^\*^](#TN1){ref-type="table-fn"}   NS                                       0         5            5               Healthy control
  Spira et al. ([@B87])                Cross-sectional             PHQ-8                       22.2                     22.7 (2.7)                              0.5                                      0         98           305             Military without mTBI Hx
  Sponheim et al. ([@B88])             Cross-sectional             BDI-II                      31.0                     33.7 (7.7)                              2.7 (0.8)                                0         9            8               Healthy control
  Strigo et al. ([@B89])               Cross-sectional             BDI-II                      23.9                     28.8 (6.6)                              4.9 (1.9)                                0         20           24              Veterans without mTBI Hx
  Suhr and Gunstad ([@B90])            Cohort                      BDI-II                      NS                       18.5 (0.8)                              NS                                       62        63           50              University peers without mTBI Hx
  Tarazi et al. ([@B91])               Cross-sectional             PAI (depression subscale)   36.1                     53.4 (10.3)                             17.3 (14.8)                              0         45           25              Healthy control
  Tremblay et al. ([@B92])             Cross-sectional             BDI                         24.0                     60.9 (7.5)                              36.9                                     0         15           15              Healthy control (former university athlete)
  Vanderploeg et al. ([@B93])          Randomized control          DSM-IV                      21.8                     37.8 (2.5)                              16.0                                     0         254          3214            Veterans without mTBI Hx
  Vasterling et al. ([@B94])           Cross-sectional             CES-D                       24.6                     25.6 (5.0)                              1.0                                      0         87           84              Military without mTBI Hx
  Vasterling et al. ([@B95])           Cross-sectional             BDI                         23.3                     48.3 (9.0)                              25                                       2         68           692             Veterans without mTBI Hx
  Verfaellie et al. ([@B96])           Cross-sectional             BDI                         27.5                     30.7 (8.7)                              3.2 (1.9)                                4         53           39              Veterans without mTBI Hx
  Waljas et al. ([@B97])               Cohort                      BDI-II                      36.8                     37.8 (13.5)                             1.1 (0.1)                                56        103          36              Healthy control
  Walker et al. ([@B98])               Cohort                      CES-D                       24.3                     25.0[^\*^](#TN1){ref-type="table-fn"}   0.7                                      3         176          40              Military without mTBI Hx
  Walker et al. ([@B99])               Cohort                      CES-D                       25.9                     27.0[^\*^](#TN1){ref-type="table-fn"}   1.1                                      6         29           58              Military & veterans without mTBI Hx
  Waterloo et al. ([@B100])            Cohort                      BDI-II                      26.4                     27.4 (15.9)                             1.0                                      43        7            7               Healthy control
  Wilk et al. ([@B101])                Cross-sectional             PHQ-15                      NS                       NS                                      NS                                       9         260          846             Military without mTBI Hx

*BDI, Beck Depression Inventory; CES-D, Center for Epidemiologic Studies Depression Scale; DSM, Diagnostic and Statistical Manual of Mental Disorders; HAMD, Hamilton Depression Rating Scale; Hx, History; ICD, International Classification of Diseases; MADRS, Montgomery-Åsberg Depression Rating Scale; mTBI, mild traumatic brain injury; NS, not stated; NSI, Neurobehavioral Symptom Inventory; PAI, Personality Assessment Inventory; PDHRA, Post-Deployment Health Assessment; PHQ, Patient Health Questionnaire; QIDS, Quick Inventory of Depressive Symptomatology; VAS, Visual Analog Scale; WHODAS, World Health Organization Disability Assessment Schedule; ZDS, Zung Depression Scale*.

*value represents median, rather than mean*.

A random-effects meta-analysis was conducted to examine the odds of depression at least 6 months after adult mTBI. We examined Forest plots of continuous and dichotomous data to assess trend similarity ([eFigures 1, 2](#SM1){ref-type="supplementary-material"}) before pooling these data. The overall OR of depression chronically after mTBI was 3.29 (95% CI 2.68--4.03, *I*^2^ = 96%, *p* \< 0.00001) at the meta-analysis level ([Figure 2](#F2){ref-type="fig"}).

![Forest plot representing pooled data from 82 studies reporting depression assessments at least 6 months after mild traumatic brain injuiry (mTBI). In each study, data for mTBI patient groups were compared with control groups for odds of depression. OR, odds ratio. Risk of bias was assessed using the SIGN methodological checklist.](fneur-11-00350-g0002){#F2}

Four studies ([@B21], [@B31], [@B72], [@B79]) accounted for a large number of the total subjects (365,480/392,834; 93%); however, this contribution largely resulted from control subjects in one study \[*n* = 221,501 ([@B31])\]. Taking into account the relative frequency of mTBI vs. control subjects, these studies each contributed \<2% of the overall weight, for a total contribution of 7.1%. No significant relationship was detected between mTBI and depression when these studies were assessed in isolation (OR 1.06, 95% CI 0.70--1.62; *I*^2^ = 100%, *p* = 0.78). However, removal of these studies from the pooled dataset only resulted in marginal change from the overall OR of post-mTBI depression (OR 3.61, 95% CI 2.89--4.52; *I*^2^ = 85%, *p* \< 0.00001).

A number of studies ([@B25], [@B28], [@B49], [@B56], [@B58], [@B61], [@B69], [@B82], [@B93]--[@B97]) described assessment of lifetime depression but did not clearly stipulate whether participants were excluded if screening positively for pre-injury depression. To determine whether these studies unduly influenced findings, we removed these studies and repeated our analysis. We found that the OR remained stable without those studies (OR 3.34, 95% CI 2.96--4.15, *I*^2^ = 94%, *p* \< 0.00001) and was similar when these studies were assessed in isolation (OR 3.13, 95% CI 1.72--5.71, *I*^2^ = 94%, *p* = 0.00002).

As a sub-analysis, we investigated the stability of the odds of post-mTBI depression over time. Studies were divided into four categories based on the distribution of time points: 6 months−1 year post-mTBI (nine studies, *n* = 1,906), 1--2 years (17 studies, *n* = 3,526), 2--10 years (27 studies, *n* = 32,093), and more than 10 years post-mTBI (six studies, *n* = 6,339). Twenty-two studies did not report a time interval post-injury and thus were excluded from this sub-analysis. No significant differences were observed between subgroups (*p* = 0.99, one-way ANOVA), although the calculated OR values were uniformly higher following the first subgroup (6 months−1 year). The meta-analysis level ORs and CIs are presented in [Figure 3A](#F3){ref-type="fig"} and were as follows: 6 months−1 year post-mTBI: OR 2.43, 95% CI 1.45--4.07, *I*^2^ = 69%, *p* = 0.0007; 1--2 years: OR 4.12, 95% CI 2.10--8.07, *I*^2^ = 92%, *p* \< 0.0001; 2--10 years: OR 3.28, 95% CI 2.42--4.46, *I*^2^ = 76%, *p* \< 0.00001; 10+ years: OR 3.23, 95% CI 2.39--4.36, *I*^2^ = 86%, *p* \< 0.00001. Three of the included studies performed longitudinal assessment with time points beyond those included in our meta-analysis. Their findings at time points relevant to our study also revealed stable depression symptoms over the following 1 ([@B41]), 5 ([@B72]), or 9 ([@B56]) years post-mTBI, with no apparent reduction in rate of depression. We next investigated whether depression persisted at a similar OR relative to age at mTBI. Studies were divided into those with mean ages of \<25 years (18 studies, *n* = 9,622) 25--35 years (29 studies, *n* = 14,652), and more than 35 years of age (12 studies, *n* = 27,243). No significant difference was found between subgroups (*p* = 0.73, one-way ANOVA), although the pooled OR for 25--35 years was numerically higher ([Figure 3B](#F3){ref-type="fig"}). The ORs were as follows: aged under 25: OR 2.26, 95% CI 1.82--2.81, *I*^2^ = 41%, *p* \< 0.00001; aged 25--35: OR 4.67, 95% CI 3.06--7.14, *I*^2^ = 87%, *p* \< 0.00001; aged over 35: OR 2.69, 95% CI 1.42--5.10, *I*^2^ = 84%, *p* = 0.002.

![Odds ratio (OR) of depression over time post mild traumatic brain injury (mTBI) **(A)** and age at injury **(B)**. **(A)** Data were stratified into early phase (6 months−1 year post-mTBI), late-early phase (1--2 years post-mTBI), intermediate phase (2--10 years post-mTBI), and late phase (more than 10 years post-mTBI). **(B)** Data were stratified by mean age at injury under 25 years, 25--35 years, or over 35 years. Dashed lines indicate the overall OR.](fneur-11-00350-g0003){#F3}

To examine the possible influence of cohort composition, we further evaluated the impact of age at assessment, biological sex, injury etiology, repeated mTBI, method of depression assessment, and study design. We tested the effect of age at assessment by dividing studies into groups where the mean age was under 40 (63 studies, *n* = 81,860) and over 40 years (15 studies, *n* = 30,650). No significant difference between groups was seen (*p* = 0.25, Student\'s *T*-test). ORs were as follows: aged under 40: OR 3.14, 95% CI 2.48--3.99, *I*^2^ = 94%, *p* \< 0.00001; aged over 40: OR 4.57, 95% CI 2.54--8.24, *I*^2^ = 87%, *p* \< 0.00001. Two studies included only females, for which the pooled OR was 147.68, 95% CI 169, 110.38, *I*^2^ = 93%, *p* = 0.16. We also compared data for the four studies which included more than 70% females (*n* = 287) to 55 studies including more than 70% males (*n* = 88,239). No statistical difference was found between males and females (*p* = 0.08, Student\'s *T*-test). The ORs were as follows: Male: OR 3.00, 95% CI 2.33--3.86, *I*^2^ = 95%, *p* \< 0.00001; Female: OR 19.97, 95% CI 2.39--166.93, *I*^2^ = 81%, *p* = 0.006.

The relationship between post-mTBI depression and injury etiology was tested by stratifying studies as sport mTBI (17 studies, *n* = 4,827), military-related mTBI (including blast-related brain injury; 34 studies, *n* = 75,348), MVAs (nine studies, *n* = 30,043), and mTBIs uncategorized or of unspecified etiology (36 studies, *n* = 311,687). There was no statistical difference in the OR of depression relative to any mTBI etiology (*p* = 0.61, one-way ANOVA). The ORs for each category were as follows: sports-related injury: OR 3.51, 95% CI 2.01--6.11, *I*^2^ = 78%, *p* \< 0.00001; military injury: OR 3.19, 95% CI 2.36--4.32, *I*^2^ = 96%, *p* \< 0.00001; MVA: OR 2.3, 95% CI 1.36--3.88, *I*^2^ = 81%, *p* = 0.002; other injury: OR 3.26, 95% CI 2.45--4.35, *I*^2^ = 88%, *p* \< 0.00001.

Repetitive injuries were reported in 35/82 (41%) of studies, with 30 (86%) of these studies reporting a majority of subjects with repetitive mTBIs. The odds of depression after repetitive or single mTBI were identical, with an OR for repetitive injuries of 3.66 (95% CI 2.56--5.22, *I*^2^ = 90%, *p* \< 0.00001) and an OR for single injuries of 3.48 (95% CI 2.56--5.73, *I*^2^ = 96%, *p* \< 0.00001).

The impact of the most frequently utilized six depression assessment methods on OR of depression after mTBI is presented in [eResults 2](#SM1){ref-type="supplementary-material"}, with no statistical difference in the OR of depression relative to assessment method. The influence of study design (cohort or cross-sectional) is presented in [eResults 3](#SM1){ref-type="supplementary-material"}, with no statistical difference observed in the odds of depression between these study designs.

Risk of bias is presented in [Figure 4](#F4){ref-type="fig"} (and [eTable 2](#SM1){ref-type="supplementary-material"}, in full), with bias risk expressed as a percentage for each assessed item. Risk of bias was greatest for multiple assessment of mTBI exposure (reported in \<25% of studies), provision of CIs, and blinding of assessment, which was infrequently reported. The vast majority of studies reported a clear objective, had an appropriate and well-defined control group, and used validated measures of depression and mTBI, with an overall evaluation of low risk of bias and high applicability of results. A funnel plot of the pooled data ([eFigure 3](#SM1){ref-type="supplementary-material"}) demonstrated substantial asymmetry, representing publication bias. The majority of studies were clustered in the top section of the plot, indicative of more precise effect estimates, with a low number of low-powered studies reporting ORs \<1. Orwin\'s Failsafe-N formula ([@B17]) showed that 115 additional studies with an OR of 1.0 would be required to decrease the effect size below a Cohen\'s *d* of 0.5.

![Risk of bias graph. Authors\' judgments for each risk of bias item are presented as percentages across all included studies.](fneur-11-00350-g0004){#F4}

Discussion {#s4}
==========

In this meta-analysis of 82 studies and 392,834 participants (96,709 mTBI subjects and 296,125 controls), we found that the OR for depression associated with mTBI (more than 6 months post-injury) was 3.29 when compared with those without a history of mTBI. Given the substantial prevalence of concussion in society, mTBI should now be considered as a significant driver of the overall population risk of depression.

A key secondary finding was that odds of depression occurring after mTBI are maintained or may even increase with chronicity and do not dissipate in the acute or subacute period. This finding indicates that "mild" TBI has repercussions extending over years, if not decades across a lifetime. Depression in the chronic recovery phase has been most frequently reported for moderate or severe injuries ([@B102]), likely because the higher degree of clinical management and follow-up these patients require renders them more accessible to researchers. In contrast to TBIs classed as moderate or severe, those experiencing mTBI are typically discharged rapidly with no or only short-term follow-up. The current Centers for Disease Control and Prevention guidelines ([@B103]) specify that patients with isolated mTBI and normal neurological evaluation can be discharged if head CT is negative, with no follow-up required unless post-concussive symptoms persist.

The consensus has been that the emotional sequelae of mTBI generally resolve by 12 weeks post-injury ([@B104]). Our data provide the first large-scale evidence to contradict this notion, highlighting a need for management strategies for mTBI to be reexamined. Further comprehensive longitudinal studies are required to elucidate this chronology. To date, a single longitudinal study has documented chronological rates of depression after TBI, following subjects (*n* = 423) monthly or every 2 months over a year ([@B105]). The authors found that depression was transient acutely but reemerged in the chronic phase, with a prevalence of 31% at 1 month and 21% at 6 months. This supports previous work suggesting that post-mTBI depression is biphasic, with transient symptomology acutely ([@B13], [@B105]) and a reemergence chronically ([@B106]). Together with this finding, our data highlight the importance of longitudinal assessment to thoroughly characterize emotional disturbance beyond the acute and subacute recovery phases ([@B107]).

We found no significant relationship between depression and the age at which mTBI occurred, although the pooled OR for those aged 25--35 years was numerically higher than those aged under 25. Several studies have now demonstrated a relationship between age at injury and risk of depression ([@B12], [@B14], [@B105]), whereby experiences of depression increase with advancing age. Although poorly understood, this may be influenced by a decrease in synaptic pruning, reduced neural plasticity, and/or diminished neurogenesis ([@B108]) as accompaniments to both depression and older age. Further research is required to determine whether a specific age vulnerability to post-mTBI depression truly exists, with potential need for age-specific management guidelines.

The role of biological sex in mTBI outcome is one of growing interest as females increasingly participate in collision sports and combat roles in military operations. Of 82 studies we included, only two exclusively examined females, while 24 focused only on male subjects. Given the disparity in outcome recoveries ([@B11]), more research is clearly needed to identify sex-specific consequences of mTBI. Including studies with more than 70% of either sex, we did not observe a statistical difference in depression, although the pooled OR for females was higher than males. There was substantial disparity between the number of subjects in these studies, potentially increasing the CIs. Ambiguity exists around the susceptibility of female sex to post-TBI depression, with several studies reporting increased post-mTBI depression in females ([@B12], [@B109]), while others have found no such relationship ([@B13]).

Blast neurotrauma and militarily acquired injuries are often excluded in meta-analyses on the assumption that these are polytrauma cases with a complicated pathology. We chose to include military injuries in our analysis to provide a full assessment of the scope of depression post-mTBI without imposing any prior assumptions on the data. While the injury modality may differ, many of these forms are also likely to include a polytrauma component (e.g., MVA, assaults) or have injury multipliers, as is the case for collision sports in which the concussed subject lands heavily on the ground. We found that the OR for depression in the chronic recovery phase was comparable no matter the etiology, suggesting that the mode of injury is not a significant factor in post-mTBI depression. This finding echoes two recent studies comparing blast vs. non-blast TBI, which reported similarities in the rate of post-traumatic outcomes ([@B61], [@B110]).

We also found that, at present, there is no compelling evidence for a cumulative effect of mTBI on post-mTBI depression, though further research is certainly required. Repetitive mTBI was documented almost entirely in the sports or military mTBI categories, for which subjects may experience many mTBIs across a career. The influence of repetitive injuries on emotional outcomes is one of contention, with several publications \[including a recent systematic review of 47 studies ([@B111])\] finding that repetitive mTBI is associated with deteriorating mental health ([@B56], [@B87]), while others have found little psychological consequences of repeated injuries ([@B112]).

Our findings should be considered in the context of several important limitations. First, bias in subject selection may have been present in these longer-term studies either by direct selection of patients for which post-concussive symptoms predominates or selection bias due to lingering problems. We found that studies overwhelmingly focused on young adults and the middle aged rather than older participants, and thus our findings may not extend to post-mTBI depression in elderly participants who are more likely to sustain mTBI from other causes, e.g., falls. We also chose not to include pediatric populations, which would require a separate analysis to examine post-mTBI depression in the context of neurodevelopment. Participants in included studies may also have experienced concomitant disorders such as anxiety or posttraumatic stress disorder (PTSD), which might influence results toward an increase or decrease in risk ([@B11]). A key inclusion criterion for our research was the presence of a validated instrument to assess the likely presence or absence of depression, chosen to ensure a maximal synthesis of the available data. Aside from structured interviews, a general limitation of these instruments is their lack of confirmatory diagnoses. However, symptom-based scales are frequently used as screening tools for depression and are unlikely to give false negatives. We also did not specify a particular severity of depression in order to avoid bias introduced by any possible threshold effect. We excluded studies for which lifetime or pre-injury depression status was documented; however, the presence of pre-injury depression could not be ruled out for the majority of studies, and therefore we cannot be certain that depression only emerged after injury. To answer this, future studies would need to employ a longitudinal design in a non-injured population (e.g., sportspeople or military) with thorough lifetime assessment of depression and monitor emergence of depression over months and years post-injury.

Our inclusion of studies with a mean time post-injury of 6 months meant that few studies had a lower time limit of \<6 months. The majority of studies we included were non-randomized cohort, case-control, cross-sectional, and prospective observational studies, and the inherent heterogeneity and risk of bias for such studies (as compared to randomized controlled trials) should be weighed in context of our findings. While the risk of bias overall was low, we found significant heterogeneity and publication bias, with the majority of high-powered studies showing either a positive or negative effect coupled with small standard errors. A small number of studies were low powered with positive findings; there were no low-powered negative studies that met our inclusion criteria. This is likely a consequence of "file-drawer" bias, for which smaller studies with negative findings are less likely to be published. Using Orwin\'s Failsafe-N formula, we found that an additional 115 low-powered negative studies would be required to skew the data toward the null hypothesis, providing confidence that our findings are robust. The high degree of between-study heterogeneity could not be explained by subgroup analyses and could potentially limit generalizability of the study results.

Our data show a positive relationship between mTBI and depression in the chronic phase of injury recovery. The size of this effect is substantial, representing a \>3-fold increase in risk of depression after 6 months post-mTBI. This finding should prompt a reevaluation of our standard of care for 42 million mTBI cases occurring per year worldwide.
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